Embla Medical hf. (CPH: EMBLA)

Market Cap	14.73B
Revenue (ttm)	5.62B
Net Income (ttm)	461.79M
Shares Out	426.93M
EPS (ttm)	1.08
PE Ratio	31.94
Forward PE	23.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	362,468
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	26.00 - 38.00
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 5, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 3,999
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2023, Embla Medical's revenue was $785.68 million, an increase of 9.33% compared to the previous year's $718.65 million. Earnings were $58.39 million, an increase of 37.34%.

Financial numbers in USD